Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TPTX

Turning Point Therapeutics (TPTX) Stock Price, News & Analysis

Turning Point Therapeutics logo

About Turning Point Therapeutics Stock (NASDAQ:TPTX)

Advanced Chart

Key Stats

Today's Range
$76.01
$76.01
50-Day Range
$74.80
$76.01
52-Week Range
$23.77
$82.20
Volume
4,322 shs
Average Volume
1.14 million shs
Market Capitalization
$3.81 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TPTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Turning Point Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

TPTX Stock News Headlines

Turning Point of Tampa Now In-Network with Blue Cross Blue Shield Insurance
Banks aren’t ready for this altcoin—are you?
In crypto, timing is everything. By the time the masses catch wind of this, the biggest gains could be ancient history. Are you ready to potentially change your financial future forever?
Turning Point Brands Inc.
Alzheimer’s: A Turning Point?
See More Headlines

TPTX Stock Analysis - Frequently Asked Questions

Turning Point Therapeutics, Inc. (NASDAQ:TPTX) posted its quarterly earnings results on Tuesday, November, 9th. The company reported ($1.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.26) by $0.08. The company earned $0.46 million during the quarter.

Turning Point Therapeutics (TPTX) raised $167 million in an initial public offering (IPO) on Wednesday, April 17th 2019. The company issued 9,300,000 shares at $18.00 per share. Goldman Sachs, SVB Leerink and Wells Fargo Securities acted as the underwriters for the IPO and Canaccord Genuity was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Turning Point Therapeutics investors own include Meta Platforms (META), Diamondback Energy (FANG), Gilead Sciences (GILD), HubSpot (HUBS), Netflix (NFLX), NVIDIA (NVDA) and Pfizer (PFE).

Company Calendar

Last Earnings
11/09/2021
Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TPTX
Fax
N/A
Employees
250
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$236.55 million
Pretax Margin
-33,959.03%

Debt

Sales & Book Value

Annual Sales
$30.83 million
Price / Cash Flow
N/A
Book Value
$15.84 per share
Price / Book
4.80

Miscellaneous

Free Float
45,768,000
Market Cap
$3.81 billion
Optionable
Not Optionable
Beta
-0.18
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:TPTX) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners